Lou G.
- Country
- France
- Department
- Neurologie
Research Overview
- Efficacy of Diroximel Fumarate in Reducing Perihaematomal Oedema in Patients with Spontaneous Intracerebral Haemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial
- Evaluation of Ketamine Hydrochloride and Magnesium Sulfate Heptahydrate Infusion Efficacy in Refractory Chronic Cluster Headache Treatment
Data & Insights
Has run more than one trial at 5 of 17 partner sites.
Specializations
Vascular Neurology and Acute Stroke
Lou GRANGEON’s clinical research activity is centered on vascular neurology and the management of acute ischemic stroke, including large-vessel occlusion, basilar artery occlusion, transient ischemic attack, and intracerebral hemorrhage. The portfolio also includes work related to post-cardiac arrest shock and critical neurovascular care.
- Acute ischemic stroke
- Transient ischemic attack
- Intracerebral hemorrhage
- Cardiac arrest
Research interests extend to neurointensive care pathways and therapies aimed at reducing early neurological injury and vascular complications in emergency settings.
Cerebrovascular Prevention and Thrombosis
The investigator is involved in studies addressing cardioembolic prevention, atrial fibrillation, venous thromboembolism, and broader atherosclerotic cardiovascular disease risk reduction. This includes therapeutic areas linked to antithrombotic strategies and secondary prevention after vascular events.
- Atrial fibrillation
- Venous thromboembolism
- Atherosclerotic cardiovascular disease
- Stroke prevention
Clinical interests also cover thrombotic risk in high-risk medical contexts and the prevention of recurrent ischemic events.
Neurodegenerative and Cognitive Disorders
Lou GRANGEON participates in research involving Alzheimer’s disease, mild cognitive impairment, frontotemporal dementia, and Parkinson’s disease. The therapeutic focus includes conditions associated with cognitive decline, neuropsychiatric symptoms, and progressive neurodegeneration.
- Alzheimer’s disease
- Mild cognitive impairment
- Frontotemporal dementia
- Parkinson’s disease
Research activity in this domain reflects interest in neurological disorders with major long-term functional impact and evolving treatment needs.
Immune-Mediated and Inflammatory Diseases
The investigator’s portfolio includes vasculitis, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, and lupus-related disease. Additional involvement spans hidradenitis suppurativa, atopic dermatitis, and other chronic inflammatory disorders requiring targeted immunomodulatory care.
- ANCA-associated vasculitis
- Rheumatoid arthritis
- Multiple sclerosis
- Atopic dermatitis
These activities align with therapeutic development in autoimmune and inflammatory conditions affecting the nervous system and systemic organs.
Critical Care and Supportive Neurology
Lou GRANGEON is also engaged in research on intensive care neurology, including severe influenza, sepsis-related complications, acute respiratory failure, and other hospitalized conditions with neurological or vascular relevance. The clinical scope includes management of acute complications in medically fragile patients.
- Neurointensive care
- Severe influenza infection
- Acute respiratory failure
- Sepsis-related complications
This area supports therapeutic innovation in acute hospital care where neurological monitoring and vascular stabilization are central.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.